EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC-ND 4.0

Statins use for primary prevention of cardiovascular disease: A population-based digitally enabled real-world evidence cross-sectional study in primary care in Brazil

Karla Santo, Raul D Santos, Alysson Nathan Girotto, Josue Nieri, Frederico Monfardini, Priscila Raupp, Pedro Marton Pereira, Otavio Berwanger, M Julia Machline-Carrion

Journal of Clinical Lipidology · 2024

DOI: 10.1016/j.jacl.2024.02.005 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Clinical Lipidology, 2024. Verfasst von Karla Santo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Israelita Albert Einstein, 755 Comendador Elias Jafet Street, room 408/409, Floor L4, Morumbi, São Paulo, SP, Postal Code 05653-000, Brazil …. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Primary Health Care, Cardiovascular Diseases, Primary Prevention. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Statins are the main strategy to reduce dyslipidemia-related cardiovascular risk. Nevertheless, there is scarce evidence on the real-world statins use in primary care settings in low-middle-income countries. OBJECTIVE: We conducted a cross-sectional retrospective study using anonymized data routinely collected by community health workers in Brazil aimed to evaluate statin use and associated factors in a primary prevention population with cardiovascular risk enhancers. METHODS: Study population consisted of adults with hypertension, diabetes, and/or dyslipidemia. The primary and secondary outcomes were the proportion of individuals self-reporting statins use on any dose and high-dose statins/high-intensity lipid-lowering therapy (LLT), respectively. RESULTS: Of the 2,133,900 adult individuals in the database, 415,766 (19.5%) were included in the study cohort. From this cohort, 89.1% had hypertension, 28.9% diabetes, and 5.5% dyslipidemia. The mean age was 61.5 (standard deviation 14.5) years, 63.4% were female, and 61.0% were of mixed-race. Only 2.6% and 0.1% of individuals self-reported the use of statins and high-dose statins/high-intensity LLT, respectively. Older age (odds ratio [OR] 1.96; 95% confidence interval [CI] 1.88, 2.05, p < 0.001), living in the South region of Brazil (OR 4.39; 95% CI 3.97, 4.85, p < 0.001), heart failure (OR 2.60; 95% CI 2.33, 2.89, p < 0.001), chronic kidney disease (OR 1.49; 95% CI 1.35, 1.64, p < 0.001), and anti-hypertensive medications use (OR 4.38; 95% CI 4.07, 4.71, p < 0.001) were independently associated with statin use. CONCLUSION: In a real-world evidence study analyzing data routinely collected in a digitized primary care setting, we observed a very low use of statins in a primary prevention population with cardiovascular risk enhancers in Brazil. Socio-demographic factors and co-morbidities were associated with higher statins use rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsPrimary Health CareCardiovascular DiseasesPrimary PreventionHumansFemaleMaleCross-Sectional StudiesBrazilMiddle AgedRetrospective StudiesAgedAdultDyslipidemias

Stichwörter der Autor:innen

Cardiovascular diseasesDigital healthPrimary preventionReal-world evidenceStatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Hospital Israelita Albert Einstein, 755 Comendador Elias Jafet Street, room 408/409, Floor L4, Morumbi, São Paulo, SP, Postal Code 05653-000, Brazil (Santo, Santos, Nieri, Monfardini and Berwanger). Electronic address:…
  • Hospital Israelita Albert Einstein, 755 Comendador Elias Jafet Street, room 408/409, Floor L4, Morumbi, São Paulo, SP, Postal Code 05653-000, Brazil (Santo, Santos, Nieri, Monfardini and Berwanger); Heart Institute (InC…
  • epHealth Primary Care Solutions, 3339 Dr. Antônio Luiz Moura Gonzaga Road, Room 107 Block A, Rio Tavares, Florianópolis, SC, Postal Code 88048-300, Brazil (Girotto and Pereira).
  • Hospital Israelita Albert Einstein, 755 Comendador Elias Jafet Street, room 408/409, Floor L4, Morumbi, São Paulo, SP, Postal Code 05653-000, Brazil (Santo, Santos, Nieri, Monfardini and Berwanger).
  • Novartis Biociências Brazil, 90 Professor Vicente Rao Avenue, Cidade Monções, São Paulo, SP, Postal Code 04706-900, Brazil (Raupp).
  • epHealth Primary Care Solutions, 3339 Dr. Antônio Luiz Moura Gonzaga Road, Room 107 Block A, Rio Tavares, Florianópolis, SC, Postal Code 88048-300, Brazil (Girotto and Pereira); epHealth UK, C/O Taylor Vinters, Floor 33…

Zitieren

APA

Santo, K., Santos, R. D., Girotto, A. N., Nieri, J., Monfardini, F., Raupp, P., Pereira, P. M., Berwanger, O., & Machline-Carrion, M. J. (2024). Statins use for primary prevention of cardiovascular disease: A population-based digitally enabled real-world evidence cross-sectional study in primary care in Brazil. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2024.02.005

Vancouver

Santo K, Santos RD, Girotto AN, Nieri J, Monfardini F, Raupp P, et al. Statins use for primary prevention of cardiovascular disease: A population-based digitally enabled real-world evidence cross-sectional study in primary care in Brazil. Journal of Clinical Lipidology. 2024. doi:10.1016/j.jacl.2024.02.005

BibTeX
@article{Santo2024,
  author = {Santo, Karla and Santos, Raul D and Girotto, Alysson Nathan and Nieri, Josue and Monfardini, Frederico and Raupp, Priscila and Pereira, Pedro Marton and Berwanger, Otavio and Machline-Carrion, M Julia},
  title = {Statins use for primary prevention of cardiovascular disease: A population-based digitally enabled real-world evidence cross-sectional study in primary care in Brazil},
  journal = {Journal of Clinical Lipidology},
  year = {2024},
  doi = {10.1016/j.jacl.2024.02.005}
}
Kostenlos starten →